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A non-canonical mismatch repair pathway in
prokaryotes
A. Castan˜eda-Garcı´a1,2, A.I. Prieto1, J. Rodrı´guez-Beltra´n1, N. Alonso3, D. Cantillon4, C. Costas1, L. Pe´rez-Lago5,
E.D. Zegeye6, M. Herranz5, P. Plocin´ski2,w, T. Tonjum6, D. Garcı´a de Viedma5, M. Paget7, S.J. Waddell4,
A.M. Rojas8, A.J. Doherty2 & J. Bla´zquez1,3,9
Mismatch repair (MMR) is a near ubiquitous pathway, essential for the maintenance of
genome stability. Members of the MutS and MutL protein families perform key steps in
mismatch correction. Despite the major importance of this repair pathway, MutS–MutL are
absent in almost all Actinobacteria and many Archaea. However, these organisms exhibit
rates and spectra of spontaneous mutations similar to MMR-bearing species, suggesting
the existence of an alternative to the canonical MutS–MutL-based MMR. Here we report
that Mycobacterium smegmatis NucS/EndoMS, a putative endonuclease with no
structural homology to known MMR factors, is required for mutation avoidance and anti-
recombination, hallmarks of the canonical MMR. Furthermore, phenotypic analysis of natu-
rally occurring polymorphic NucS in a M. smegmatis surrogate model, suggests the existence
of M. tuberculosis mutator strains. The phylogenetic analysis of NucS indicates a complex
evolutionary process leading to a disperse distribution pattern in prokaryotes. Together, these
findings indicate that distinct pathways for MMR have evolved at least twice in nature.
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C
ells ensure the maintenance of genome stability and a low
mutation rate using a plethora of DNA surveillance and
correction processes. These include base selection, proof-
reading, mismatch repair (MMR), base/nucleotide excision repair,
recombination repair and non-homologous end-joining1. The
recognized MMR pathway is highly conserved among the three
domains of life2. In all cases, members of the MutS and
MutL protein families perform key steps in mismatch
correction. This MutS–MutL-based MMR system (canonical
MMR) is a sophisticated DNA repair pathway that detects and
removes incorrect mismatched nucleobases. Mismatched base
pairs in DNA arise mainly as a result of DNA replication
errors due to the incorporation of wrong nucleobases by
DNA polymerases. To correct them, the system detects
incorrect although chemically normal bases that are
mismatched with the complementary strand, discriminating
between the parental template and the newly synthesized
strand3.
Loss of this activity has very important consequences, such
as high rates of mutation (hypermutability) and increased
recombination between non perfectly identical (homeologous)
DNA sequences4, both hallmarks of MMR inactivation.
Nevertheless, despite the quasi-ubiquitous nature of this
pathway, there are some important exceptions. The genomes
of many Archaea, including Crenarchaeota and a few groups
of Euryarchaeota, and almost all members of the bacterial
phylum Actinobacteria, including Mycobacterium, have been
shown to possess no identiﬁable MutS or MutL homologues5–7.
However, these prokaryotes exhibit rates and spectra of spon-
taneous mutations similar to canonical MMR-bearing bacterial
species8–10, suggesting the existence of unidentiﬁed mechanisms
responsible for mismatch repair.
To identify novel mutation avoidance genes in mycobacteria,
we performed a genetic screen and discovered that inactivation
of the MSMEG_4923 gene in Mycobacterium smegmatis, encod-
ing a homologue of an archaeal endonuclease dubbed
NucS (for nuclease speciﬁc for ssDNA)11, produced
a hypermutable phenotype. NucS from Pyrococcus abyssi was
initially identiﬁed as a member of a new family of novel structure-
speciﬁc DNA endonucleases in Archaea11. Notably, a recent
report revealed that the protein NucS from the archaeal species
Thermococcus kodakarensis (renamed as EndoMS) is
a mismatch-speciﬁc endonuclease, acting speciﬁcally on double-
stranded DNA (dsDNA) substrates containing mismatched
bases12. The possibility that a non-canonical mismatch repair
could be triggered by a speciﬁc double-strand break (DSB)
endonuclease, able to act at the site of a mispair, followed by
DSB repair was hypothesized 30 years ago13. The archaeal NucS
binds and cleaves both strands at dsDNA mismatched substrates,
with the mispaired bases in the central position, leaving
5-nucleotide long 50-cohesive ends12. Consequently, it has been
suggested that these speciﬁc DSBs may promote the repair of
mismatches, acting in a novel MMR process12. Moreover, very
recently, the structure of the T. kodakarensis NucS-mismatched
dsDNA complex has been determined, strongly supporting the
idea that NucS acts in a mismatch repair pathway14. Although
these biochemical and structural studies have shed some light on
the role of NucS at the molecular level, the cellular and biological
function of NucS and its impact on genome stability remains
unknown.
Hypermutable bacterial pathogens, very often associated
with defects in MMR components, are frequently isolated
and pose a serious risk in many clinical infections15–21. The
major pathogen Mycobacterium tuberculosis appears to be
genetically isolated, acquires antibiotic resistance exclusively
through chromosomal mutations22 and presents variability in
mutation rates between strains23. These factors should contribute
to the selection of hypermutable M. tuberculosis strains under
antibiotic pressure, as it occurs with other chronic pathogens18,23.
However, hypermutable strains have not yet been detected in this
pathogen. To investigate the possible existence of M. tuberculosis
hypermutable strains affected in NucS activity, we analysed
the effect of naturally occurring polymorphisms in nucS from
M. tuberculosis clinical isolates on mutation rates, using
M. smegmatis as a surrogate model.
In this study, we ﬁrst establish that NucS is essential
for maintaining DNA stability, by preventing the acquisition of
DNA mutations inMycobacterium and Streptomyces. Inactivation
of nucS in M. smegmatis produces speciﬁc phenotypes that mimic
those of canonical MMR-null mutants (increased mutation rate,
biased mutational spectrum and increased homeologous recom-
bination). Finally, we conduct here distribution and phylogenetic
analyses of NucS across the prokaryotic domains to understand
its evolutionary origins.
Results
Identiﬁcation and characterization of M. smegmatis nucS.
To identify novel mutation avoidance genes in mycobacteria,
a M. smegmatis mc2 155 library of B11,000 independent trans-
poson insertion mutants was generated and screened for spon-
taneous mutations that confer rifampicin resistance (Rif-R),
used as a hypermutator hallmark (Fig. 1a). One transposon
insertion, which inactivated the MSMEG_4923 (nucS) gene,
conferred a strong hypermutable phenotype. The NucS/EndoMS
translated protein sequence is 27% identical to NucS from
the hyperthermophilic archaeal P. abyssi and 87% to that of
M. tuberculosis (Fig. 1b). P. abyssi NucS was deﬁned as the ﬁrst
member of a new family of structure-speciﬁc endonucleases with
a mismatch-speciﬁc endonuclease activity11,12 containing an
N-terminal DNA-binding domain and a C-terminal RecB-like
nuclease domain11. All the catalytic residues required for nuclease
activity in P. abyssi are conserved in the mycobacterial NucS
(Fig. 1b).
Recombinant M. smegmatis NucS was expressed and puriﬁed.
The apparent molecular mass of the puriﬁed native protein ﬁts
with the expected size (25 kDa) (Supplementary Fig. 1A). The
biochemical activity was analysed by DNA electrophoretic
mobility shift assays (EMSAs) and nuclease enzymatic assays.
M. smegmatis NucS was capable of binding to single-stranded
DNA (ssDNA), as seen in the archaeal P. abyssi NucS11, but not
to dsDNA (Fig. 1c). Regarding cleavage of mismatched substrates,
no signiﬁcant speciﬁc cleavage activity was observed on different
substrates containing a single nucleotide mismatch in the central
region of the strand (Supplementary Fig. 1B), in contrast with
previous results obtained with the archaeal T. kodakarensis
NucS12. The binding to ssDNA indicates that the protein is
correctly folded, as it can bind to its substrate. This suggests that
different requirements, such as the binding of additional partners,
protein modiﬁcations or different DNA substrates, may be
required to activate the mismatch-speciﬁc cleavage activity of the
bacterial NucS.
NucS is essential to maintain low levels of spontaneous mutation.
To verify that NucS has a key role in maintaining DNA ﬁdelity,
we constructed an in-frame deletion of nucS (DnucS, nucS-null
derivative) in M. smegmatis and measured the rate at which
drug resistance was acquired. Notably, the nucS-null strain
displayed a hypermutable phenotype, increasing the rate
of spontaneously emerging rifampicin and streptomycin
(Str-R) resistances by a factor of 150-fold and 86-fold, respec-
tively, above the wild-type strain (3.1 10 7 versus 2.1 10 9
ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms14246
2 NATURE COMMUNICATIONS | 8:14246 |DOI: 10.1038/ncomms14246 | www.nature.com/naturecommunications
and 4.8 10 8 versus 5.6 10 10, DnucS versus wild type,
respectively). These results are equivalent to those observed for
mutS- or mutL-deﬁcient Escherichia coli (102–103-fold increa-
ses)24. Signiﬁcantly, basal mutation rates were recovered when the
nucS deletion was chromosomally complemented with the wild-
type gene MSMEG_4923 (nucSSm) (Fig. 2a, Supplementary
Table 1), conﬁrming that inactivation of this gene was
responsible for the high mutation rates observed.
Notably, M. smegmatis mc2 155 and its DnucS derivative
produced a different mutational signature. While spontaneous
MSRVRLVIAQCTVDYIGRLTAHLPSARRLLLFKADGSVSVHADDRAYKPLNWMSPPCWLTENucS_Mtu   1
--- RLVIAQCTVDYVGRLTAHLPSARRLLLFKADGSVSVHADDRAYKPLNWMSPPCWVTENucS_Msm   1
HGGVVTIFARCKVHYEGRAKSELGEGDRIIIIKPDGSFLIH-QNKKREPVNWQPPGSKVTFNucS_Pab  25
ESG-GQAPVWVVENKAGEQLRITIEGIEHDSSHELGVDPGLVKDGVEAHLQALLAEHIQLLNucS_Mtu  62
QDTETGVALWVVENKTGEQLRITVEDIEHDSHHELGVDPGLVKDGVEAHLQALLAEHVELLNucS_Msm  59
KEN-S---IISIRRRPYERLEVEIIEPYSLVVFLAEDYEELALTGSEAEM-ANLIFENPRVNucS_Pab  85
G--EGYTLVRREYMTAIGPVDLLCSDERG-GSVAVEIK-RRGEIDGVEQLTRYLELLNRDSNucS_Mtu 122
G--AGYTLVRREYPTPIGPVDLLCRDELG-RSVAVEIK-RRGEIDGVEQLTRYLELLNRDSNucS_Msm 120
IEEGFKPIYRE-KPIRHGIVDV-MGVDKDGNIVVLELKRRKADLHAVSQLKRYVDSLKEEYNucS_Pab 141
VLAPVKGVFAAQQIKPQARILATDRGIRCLTLDYDTMRGMDSGEYRLFNucS_Mtu 179 226
LLAPVAGVFAAQQIKPQARTLATDRGIRCVTLDYDQMRGMDSDEYRLFNucS_Msm 177 224
GE-NVRGILVAPSLTEGAKKLLEKEGLEFRKLEPP-KKG---------NucS_Pab 200 236
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Figure 1 | Identification and characterization of M. smegmatis NucS. (a) Schematic representation of the process for identifying the nucS transposon
mutant. B11,000 clones from the M. smegmatis insertion mutant library were replicated onto plates with (Rif) or without (No Rif) rifampicin (step 1).
One single clone (circled) produced a high number of Rif-R colonies. After isolation and purification (step 2), the frequency of spontaneous Rif-R mutants
(bottom plate) was checked and compared with that of the wild-type (upper plate), demonstrating its hypermutable phenotype. (b) Multiple sequence
alignment of NucS sequences. M. tuberculosis (NucS_Mtu), M. smegmatis (NucS_Msm) and P. abyssi (NucS_Pab) sequences are from Uniprot
(identifiers are P9WIY4, A0R1Z0 and Q9V2E8, respectively). Solid lines over the alignment indicate protein domains as defined previously for P. abyssi
NucS11 (black, DNA-binding; grey, nuclease). Identical amino acid residues are shown in black. Catalytic residues required for nuclease activity in P. abyssi
NucS11 are labelled with asterisks. Nuclease motifs of P. abyssi NucS are also indicated11. (c) DNA-binding activity of NucS. In a gel-based EMSA, purified
NucS protein (1–16mM) is capable of binding to 45-mer ssDNA (50 nM) (left side) but not to 45-bp dsDNA (50nM) (right side). The arrow indicates the
position of the DNA–NucS complex.
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Rif-R mutations detected in the wild-type strain comprise
different base substitutions, including transitions, but also
transversions and even an in-frame deletion, all mutations
detected in the DnucS strain were speciﬁcally transitions
(A:T-G:C or G:C-A:T) (Fig. 2b, Supplementary
Tables 2A,B). Transitions occur much more frequently than
transversions or indels in any cell, due to spontaneous or induced
errors in the DNA, and are the preferred substrates for
MMR mechanism. The DnucS strain accumulates a high number
of uncorrected transitions, masking transversions and indels to
undetectable levels under our experimental conditions. This
transition-biased mutational spectrum is a hallmark signature of
canonical MMR pathway25,26.
To demonstrate the generality of the mutation-avoidance
activity in species encoding NucS, the nucS gene was deleted in
Streptomyces coelicolor A3(2), a different actinobacterial species.
The precise deletion of nucS in this species increased the rate of
spontaneous mutations conferring Rif-R and Str-R by a factor of
108-fold and 197-fold, respectively. As with M. smegmatis, low
mutation rates were recovered by complementation with the
wild-type S. coelicolor nucS gene (Fig. 2c, Supplementary Table 3).
Together, these results highlight the essential role of NucS in
mutation avoidance.
NucS inhibits homeologous but not homologous recombination.
These results prompted us to investigate whether NucS is
involved in reduction of recombination between non-identical
(homeologous) DNA sequences, but not between 100% identical,
as described for the canonical MMR-null mutants in other
bacterial species4,27. The rates of recombination between
homologous and homeologous sequences were measured using
speciﬁc engineered tools (Fig. 3a, Supplementary Fig. 2A,B).
Recombination rates between 100% identical sequences were
similar in the wild-type and its DnucS derivative (2.42 10 6
and 2.86 10 6, respectively). However, when the identity
of DNA sequences decreased, the recombination rate
was comparatively higher in the nucS-null derivative:
95%, 4.68 10 7 versus 1.41 10 6 (3-fold difference),
90%, 1.71 10 8 versus 1.82 10 7 (10-fold) and
85%, 6.47 10 9 versus 3.36 10 8 (5-fold) for wild type
versus DnucS, respectively (Fig. 3b). We veriﬁed that
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Figure 2 | Mutational effects of nucS deletion. (a) Rates of spontaneous mutations conferring rifampicin, Rif-R (red), and streptomycin resistance,
Str-R (grey) of M. smegmatis mc2 155 (WT), its DnucS derivative and the DnucS strain complemented with nucS from M. smegmatis mc2 155 (nucSSm).
(b) Mutational spectrum of M. smegmatismc2 155 (green) and its DnucS derivative (red). Bars represent the frequency of the types of change found in rpoB.
(c) Rates of spontaneous mutations conferring Rif-R (red) and Str-R (grey) of S. coelicolor A3(2) M145 (WT), its DnucS derivative and the DnucS strain
complemented with the wild-type nucS from S. coelicolor (nucSSco). Error bars represent 95% confidence intervals (n¼ 20). Asterisks denote statistical
significance (Likelihood ratio test under Luria-Delbruck model, Bonferroni corrected, P value o104 in all cases). Mutation rate: mutations per cell per
generation.
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Figure 3 | Effect of nucS deletion on recombination. (a) Chromosomal
construct used to measure recombination between homologous or
homeologous DNA sequences. The hyg gene is reconstituted by a single
recombination event between two 517-bp overlapping fragments (striped),
sharing different degree of sequence identity (100%, 95%, 90% and 85%)
and separated by a kanamycin resistant (Kan-R) gene. Recombinant clones
express hygromycin resistance and kanamycin susceptibility. (b) Rates of
recombination between homologous and homeologous DNA sequences
with different degree of identity (%) in M. smegmatis mc2 155 (WT, green
squares) and its DnucS derivative (red diamonds). Error bars represent
95% confidence intervals (n¼ 16). Asterisks denote statistical significance
(Likelihood ratio test under Luria–Delbruck model, Bonferroni corrected,
P value o104 in all cases).
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recombinants detected were exclusively due to recombination
events but not spontaneous mutation (see ‘Methods’ section). The
inhibitory effect of NucS on homeologous but not homologous
recombination again resembles an important tell-tale signature of
a canonical MMR pathway28,29.
NucS polymorphisms in M. tuberculosis clinical strains. Once
the possibility of hypermutability was demonstrated in
M. smegmatis, we searched for the existence of M. tuberculosis
hypermutable clinical isolates by nucS inactivation. Analysis of
the nucSTB sequences fromB1,600 clinicalM. tuberculosis strains
available in the databases revealed a total of nine missense single
nucleotide polymorphisms (SNPs) (Supplementary Table 4,
Supplementary Fig. 3). The effects of these polymorphisms on
NucS activity were experimentally analysed by checking their
impact on mutation rates, using a M. smegmatis heterologous
system, as previously reported for other mutagenesis studies30.
Ten nucSTB alleles (nine polymorphic plus the wild type) were
integrated into the chromosome of M. smegmatis DnucS.
Complementation with wild-type nucSTB restored low mutation
rates to M. smegmatis DnucS. However, ﬁve alleles increased
mutation rate signiﬁcantly (Fig. 4, Supplementary Table 5), with
allele S39R presenting the strongest observed mutator phenotype
(83-fold increase). Alleles A135S, R144S, T168A and K184E
produced increases in mutation rates close to one order of
magnitude, whereas alleles S54I, A67S, V69A and D162H
produced low increases (B2) or no changes. These results
suggest the existence of hypermutable M. tuberculosis clinical
strains affected by modulation of NucS activity.
NucS taxonomic distribution. Taken together, our results
compellingly suggest a functional connection between NucS and
known MMR pathways. We analysed the species distribution of
NucS taking also into account the canonical MMR proteins, MutS
and MutL (for MutS and MutL analyses see Supplementary
Methods). A total of 3,942 reference proteomes were scanned for
presence/absence of NucS (Supplementary Data 1, Supplementary
Fig. 4). Bacteria are represented by 2,709 proteomes (68%)
and Archaea by 132 (4%), the remaining 1,101 (28%) belonging
to Eukaryota and Virus. NucS is present in 370 organisms,
from the domains Archaea (60 species) and Bacteria (310 species)
(Supplementary Data 1). It is totally absent from eukaryotes
and virus.
To highlight the distribution of NucS in all organisms, we built
a phylogenetic proﬁle of NucS. Figure 5 shows this proﬁle
mapped onto the NCBI taxonomy tree, containing 2,186 bacterial
and archaeal species (Supplementary Data 2). The NucS
distribution pattern indicates that this protein exhibits a disperse
distribution (Fig. 5, Supplementary Data 1).
In Bacteria, the phylum Actinobacteria is the one contai-
ning the majority of NucS with 300 species in the class
Actinobacteria (only two exceptions) and three species in other
classes of the phylum (Supplementary Data 1), Conexibacter
woesei (class Thermoleophilia), Patulibacter medicamentivorans
(class Thermoleophilia) and Ilumatobacter coccineus
(class Acidimicrobiia). All the analysed members of the class
Coriobacteriia, from the Actinobacteria phylum, lack NucS and
MutS–MutL proteins, while the two species from the class
Rubrobacteria lack NucS, but present MutS–MutL. The pattern is
even more disperse in Archaea. From 132 species, 60 have
NucS (21 also contain MutS–MutL). NucS, but not MutS–MutL,
is present in 17 out of 24 species of the phylum Crenarchaeota
and in 18 out of 88 of the phylum Euryarchaeota. By contrast,
MutS–MutL (but not NucS) is completely absent in crenarch-
aeotal species while it is restricted to 29 euryarchaeotal species
(Supplementary Data 1).
Interestingly, only 28 organisms, 21 halobacterial species
(domain Archaea) and 7 species of the phylum Deinococcus-
Thermus (domain Bacteria), have both NucS and MutS–MutL
sequences. Notably, when we focused our analysis in the two
main NucS-containing groups (Actinobacteria and Archaea),
some species still lack both NucS and MutS–MutL (conﬁrmed by
protein translated searches -tblastn- in Actinobacteria and
Archaea, Supplementary Data 1).
A model for the origin and evolution of NucS. Our results
support a complex evolutionary ancestry for NucS. Comprehen-
sive protein sequence analyses of NucS indicate that the
protein contains two distinct regions, a DNA-binding N-terminal
domain (NucS-NT) and an endonuclease C-terminal
domain (NucS-CT) (Supplementary Figs 3 and 4), in agreement
with previous structural studies11. At the sequence level,
using proﬁle hidden Markov models (HMMs), we also
detected these regions in alternative proteins outside the
context of NucS, supporting the original independence of
these domains, which have been subsequently fused during
evolution.
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Figure 4 | Effects of NucS polymorphisms on mutation rates in the M. smegmatis DnucS surrogate model. Rates of spontaneous mutations conferring
Rif-R of the M. smegmatis DnucS complemented with wild-type nucSTB (DnucS/nucSTB; red) or containing each of the nine polymorphisms indicated (blue).
Relative increases in mutation rates with respect to the control strain (DnucS/nucSTB; set to 1) are shown inside the column. Error bars represent 95%
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**Po0.005). Mutation rate: mutations per cell per generation.
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To understand the particular distribution observed in
the phylogenetic proﬁle, we conducted sequence and phylogenetic
independent analyses of full NucS and also the N-terminal
and C-terminal regions (Supplementary Figs 5–7). The actino-
bacterial NucS representatives are well separated from those
of Archaea. On the other hand, the NucS from Deinococcus-
Thermus species group together with the archaeal
proteins, instead of the actinobacterial orthologues, suggesting
that NucS has recently been transferred from Archaea to
these Deinococcus-Thermus species (Supplementary Figs 5–7).
The sequence analyses provide different distributions for
the two regions of NucS. While the N-terminal region is
limited exclusively to Archaea and some Bacteria (Supple-
mentary Fig. 7), the C-terminal region was found in many
archaeal species, some Bacteria, and in a few eukaryotes
(Supplementary Fig. 6) and, importantly, also in different domain
architectures. These observations, in the context of our
phylogenetic analyses, suggest that both regions may have
emerged in Archaea. Subsequently, the C-terminal region
may have been transferred to some bacterial species and to
a few eukaryotes, and got ﬁxed in different protein contexts.
The full protein and the individual domains likely got lost in
certain groups during the evolution of Archaea. However, the
reconstruction of the precise evolution of these individual
domains requires deeper analyses in the context of related
protein domains.
Phylogenetic analysis of the full protein suggests that NucS
emerged after the archaeal divergence by a rearrangement of
these domains and then it was transferred from Archaea to
certain Deinococcus-Thermus species in at least one event. For
Actinobacteria, the most parsimonious explanation suggests a
horizontal transfer event of NucS from Archaea coupled with a
likely MutS–MutL loss event in the last common ancestor of
Actinobacteria (as most of the contemporary NucS-encoding
species lack MutS and MutL). This is consistent with the fact that
we did not ﬁnd any species from the entire Bacteria group, except
those from Actinobacteria and the Deinococcus-Thermus group,
having NucS or NucS-like proteins. Our model (Fig. 6) favours
the simplest scenario to explain the complex pattern distribution
of the full NucS protein and its absence in all eukaryotes, the vast
majority of bacteria, and some archaeal organisms without
invoking unlikely massive losses. This is in agreement with our
phylogenetic observations.
Discussion
This study provides genetic and biological evidence that establish
the existence of a DNA repair system that mimics the canonical
MutS–MutL-based MMR pathway.
To date, the correction of mismatched nucleobases has
been deﬁned as a highly conserved mechanism whose key
steps are performed, in all cases, by members of the MutS and
MutL protein families. Despite the genomes of Crenarchaeota,
a few groups of Euryarchaeota and almost all members of
the phylum Actinobacteria lacking identiﬁable MutS or
MutL homologues5–7, they exhibit rates and spectra of spon-
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taneous mutations similar to canonical MMR-bearing bacterial
species8–10, suggesting the existence of still undetected pathway
responsible for this type of correction. Although recent
biochemical and structural reports suggested the existence of
a novel mismatch-speciﬁc endonuclease, NucS, in the archaeal
species T. kodakarensis12,14 that is able to recognize and cleave
mismatched bases in dsDNA in vitro, no genetic and/or biological
evidence had been reported to date on the activity of a novel
mismatch repair pathway.
The screening of a large library of M. smegmatis mutants
revealed that NucS is a key mutation avoidance component in
Actinobacteria. Through genetic and biological analysis, we
demonstrate that the nucS-null phenotypes in M. smegmatis are
almost identical to those produced by the MMR deﬁciency
in other bacteria (very high mutation rates, transition-
biased mutational spectrum and increased homeologous recom-
bination rates). The anti-mutator nature of NucS is
also demonstrated in Streptomyces coelicolor, a different species
of the class Actinobacteria. Therefore, NucS appears to be
an important DNA repair factor which, together with the
high-ﬁdelity DNA-polymerase DnaE1 and its PHP domain-
proofreader30, maintain low mutation rates (B10 10 mutations
per base per generation9,10), ensuring genome stability and
DNA ﬁdelity in mycobacteria and in other Actinobacteria.
Although SNPs in DNA repair/replication genes have been
suggested as a source of hypermutation in M. tuberculosis31,32,
only small increases in mutation rates have been observed
due to these polymorphic genes (for example, polymorphisms in
PHP exonuclease domain of the DNA-polymerase DnaE1
(ref. 30)). Our results suggest the existence of naturally
occurring hypermutable M. tuberculosis variants with
diminished NucS activity. Whether or not this is relevant
for the virulence and adaptation to antibiotic treatments
remains to be deciphered.
Although we observed that puriﬁed mycobacterial NucS
binds to ssDNA but not to dsDNA, as described for archaeal
NucS proteins11,12, no signiﬁcant speciﬁc cleavage activity was
observed on mismatched substrates, suggesting that activation by
other partners and/or modiﬁcations (for example, post-
translational modiﬁcations) is required in M. smegmatis.
Also, the possibility of a functional difference between bacterial
and archaeal NucS cannot be ruled out. Therefore, additional
studies are needed to assess whether mycobacterial and archaeal
NucS proteins have the same functional requirements.
Our computational studies support an archaeal origin for
NucS, as previously suggested12, built upon two distinct domains
that suffered a complex evolutionary history of transfers and/or
losses, including at least two HGT events to Actinobacteria and
Deinococcus-Thermus. Indeed, the contribution of horizontal
gene transfer in bacterial and archaeal evolution is well-
established33,34. Interestingly, NucS and MutS–MutL systems
seem to be present alternatively in different species, with only a
few exceptions. In Actinobacteria, it is possible that the
acquisition of NucS may have facilitated the subsequent loss of
MutS–MutL, as these canonical proteins are so widely conserved
across Bacteria.
On the other hand, there are two groups (Halobacteria and
some Deinococcus-Thermus) where NucS and MutS–MutL
coexist. Notably, in a Halobacteria, Halobacterium salinarum,
inactivation of mutS or mutL produced no hypermutability35,
suggesting that MutS and MutL are redundant to an alternative
system that controls spontaneous mutation. This indicates that
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evolution of these particular species may have opted to keep both
systems. The possible interplay between both pathways remains
to be elucidated. Surprisingly, NucS and MutS–MutL are
apparently absent in some species. Therefore, the possible
existence of additional alternative MMR repair pathways, yet to
be identiﬁed, cannot be discarded.
In conclusion, we propose that MMR is a mechanism that
can be either accomplished by either the MutS-L or the
NucS pathway. Understanding the mechanisms and pathways
that inﬂuence genome stability may unveil new strategies to
predict and combat the development of drug resistance.
In addition, engineered Mycobacterium strains lacking this
mutation-avoidance pathway, may be valuable tools for evaluat-
ing anti-tuberculosis treatments, including new drugs, drug
combinations and non-antibiotic based regimes.
Methods
Bacterial strains and growth conditions. M. smegmatis wild-type strain
mc2 155 and its mutant derivatives were grown at 37 C in Middlebrook 7H9 broth
or Middlebrook 7H10 agar (Difco) with 0.5% glycerol and 0.05% Tween 80,
and enriched with 10% albumin-dextrose-catalase (Difco). E. coli strains were
cultured at 37 C in LB medium. Streptomyces coelicolor A3(2) M145 and its
derivatives were grown at 30 C on mannitol–soya (MS) agar.
All primers used in this work are listed in Supplementary Table 6.
Generation and screening of a M. smegmatis insertion library. Transposon
FMycoMarT7 (ref. 36) was used to obtain a M. smegmatis mutant library of
11,000 independent clones. For transduction, M. smegmatis mc2 155 cultures
were washed, mixed with the phage stock at a multiplicity of infection of
1:10 (37 C, 3 h) and plated on kanamycin (25 mgml 1). The insertion mutants
were isolated and inoculated into 96-well microtiter plates containing Middlebrook
7H9 medium. To identify hypermutators, each mutant was inoculated onto
7H10 agar plates with rifampicin (20 mgml 1). One transposon mutant, producing
a high number of rifampicin resistant (Rif-R) colonies, was selected for further
characterization. The transposon insertion site in the chromosome was determined
by sequencing.
Generation of a DnucS knockout mutant in M. smegmatis. M. smegmatis
DnucS (MSMEG_4923, nucSSm) in-frame deletion mutant was generated by allelic
replacement37. Brieﬂy, p2NIL-DnucSSm, harbouring an in-frame deletion of the
target gene, was electroporated into M. smegmatis mc2 155. Single-crossover
merodiploid clones were isolated and after that, counter-selected to generate the
unmarked deletion by a second crossover event. Finally, putative M. smegmatis
DnucS colonies were checked by PCR and sequencing. For additional details see
Supplementary Methods.
Complementation of the M. smegmatis DnucS mutant. For complementation,
a wild type of the MSMEG_4923 gene (nucSSm) and the wild-type full-length
MT_1321 gene from CDC1551 control strain (nucSTB), including their own
promoter regions, were cloned into the vector pMV361 (ref. 38) and introduced
into M. smegmatis DnucS by electroporation. pMV361 is an integrative vector that
carries a site-speciﬁc integration system derived from the mycobacteriophage L5. It
integrates at a single site in the M. smegmatis chromosome, the attB, which
overlaps the 30 end of the tRNA-glycine gene39. Integration at the appropriate site
was veriﬁed for all constructs by PCR. For additional details see Supplementary
Methods.
DnucS S. coelicolor knockout mutant and complementation. S. coelicolor
DnucS (gene SCO5388, nucSSco) in-frame deletion mutant was constructed by
double crossover recombination using the plasmid pIJ6650 (ref. 40). pIJ-DnucSSco
(containing the in-frame deletion of the nucSSco gene) was introduced in
S. coelicolor A3(2) M145 to generate the unmarked deletion of the nucSSco gene.
Finally, S. coelicolor DnucS was complemented with a wild-type copy of nucSSco
inserted in the attB site of the S. coelicolor DnucS via the integrative vector
pSET152 (Supplementary Methods).
Estimation of mutation rates. Fluctuation analyses were used to experimentally
address mutation rates. For each experiment, 20 independent cultures of
M. smegmatis mc2 155 and its derivatives were grown and diluted to inoculate
1,000–10,000 cells per ml into fresh medium. All the cultures were incubated until
they reached stationary phase (about 109 cells per ml). Appropriate dilutions were
plated on Middlebrook 7H10 medium with or without rifampicin (100 mgml 1) or
streptomycin (50 mgml 1). For S. coelicolor, 20 independent concentrated spore
suspensions (containing B109 spores per ml) from each analysed strain were
generated on MS agar, and after that, plated on MS agar with or without rifampicin
(100 mgml 1) or streptomycin (50 mgml 1). At least three different experiments
were performed for each ﬂuctuation analysis in both cases.
The expected number of mutations per culture (m) and 95% conﬁdence
intervals were calculated using the maximum likelihood estimator applying the
newton.LD.plating and conﬁnt.LD.plating functions that account for differences in
plating efﬁciency implemented in the package rSalvador (http://eeeeeric.com/
rSalvador/) (Qi Zheng. Rsalvador: an assay. R package version 1.3) for R (www.R-
project.org/). Mutation rates (mutations per cell per generation) were then
calculated by dividing m by the total number of generations, assumed to be roughly
equal to the average ﬁnal number of cells. Statistical comparisons were carried out
by the use of the LRT.LD.plating function of the same package, which accounts for
the differences in ﬁnal number of cells and plating efﬁciency. Finally, in case of
multiple comparisons P values were corrected by the Bonferroni method.
Characterization of the mutational spectrum. The mutational spectra conferred
by M. smegmatis mc2 155 and its DnucS derivative were characterized by selecting
for resistance to rifampicin and sequencing the rifampicin resistance-determining
region in the rpoB gene, from independent Rif-R isolates.
Recombination assays. The recombination assay vectors (pRhomyco series) were
generated by cloning two overlapping fragments of the hygromycin-resistance gene
(hyg), from pRAM41, ﬂanking a functional kanamycin-resistance (kan) gene in
the pMV361 plasmid (Supplementary Fig. 2). Neither of the fragments of
hyg conferred resistance to hygromycin on their own. Fragments share a duplicated
517 bp overlapping region, with different degrees of sequence identity
(100, 95, 90 or 85%). M. smegmatis mc2 155 and its DnucS derivative were
transformed by electroporation with the integrative plasmids pRhomyco
100%, 95%, 90% and 85% designed for the recombination assays and plated
on Middlebrook 7H10 containing kanamycin (25mg ml 1). Integration
of pRhomyco vectors in the appropriate site (attB) of the M. smegmatis
mc2 155 (wild type and DnucS) chromosome was veriﬁed by PCR.
To measure recombination rates, we analysed the restoration of a functional
hyg gene that confers Hyg-R by a recombination event between the two
overlapping fragments of the hyg gene. Sixteen independent overnight cultures
from each strain were grown in Middlebrook 7H9 broth plus kanamycin
(to prevent the selection of Hyg-R bacteria coming from the early recombination of
pRhomyco). Approximately, 104 bacteria were inoculated in plain 7H9 broth
(without kanamycin) to allow the recombination events and cultured 24 h at
37 C with shaking. Cultures were plated on 7H10 plus 50 mgml 1 hygromycin
(for recombinant cells count) and in addition, appropriate dilutions were plated on
plain 7H10 (for viable cell counts) and incubated for 3–5 days. Total number of
Hyg-R colonies was considered to calculate recombination rates. Recombination
rates were calculated and analysed as described in estimation of mutation rates.
To validate the recombination assay, we ﬁrst veriﬁed that no Hyg-R colonies
were generated by spontaneous mutation, even in the DnucS derivative. The
mutation rate was r1 10 10 for the hypermutable derivative, far below the
lowest recombination value (6 10 9 for WT, 15% non-identical sequences).
These results indicate that the Hyg-R colonies from our recombination assay were
not generated by spontaneous mutations. Moreover, we veriﬁed that recombinant
clones express hygromycin resistance and kanamycin susceptibility by picking
20–30 Hyg-R colonies from each strain onto kanamycin plates. In all cases they
were Hyg-R and Kan-S. Finally, we randomly isolated 10 independent Hyg-R
presumptive recombinant colonies from each construct (80 colonies total) and
veriﬁed by PCR that a single fragment of the size of the reconstituted hyg gene was
ampliﬁed in all cases.
NucS purification and biochemical activity. M. smegmatis nucS was cloned
as a SUMO fusion and expressed in E. coli BL21 cells overnight at 16 C. NucS
protein was puriﬁed by afﬁnity chromatography using Ni2þ–NTA agarose
column followed by an additional step of anion exchange puriﬁcation in HiTrap
Q HP column. NucS-SUMO fusion was cleaved by Ulp protease to release a native
protein. Puriﬁed protein was collected and concentrated to perform the activity
assays (Supplementary Fig. 1A). In addition, His-tagged M. smegmatis nucS was
also cloned in pET28b (for E. coli expression) and pYUB28b (for M. smegmatis
expression). His-tagged NucS was also puriﬁed by afﬁnity chromatography and
anion exchange puriﬁcation as described before.
For DNA EMSA assays, NucS puriﬁed protein (1–16 mM) was incubated with
ﬂuorescein-labelled ssDNA (45-mer DNA, 50 nM) or dsDNA (45 bp DNA, 50 nM),
in 50mM Tris–HCl (pH 7.5), 1mM EDTA, 10% glycerol and 10 mgml 1 BSA for
30min at 37 C. Protein–DNA complexes were resolved on 5% polyacrylamide gel
in  0.25 TBE plus 1% glycerol and run under refrigerated conditions (5–10 C).
For nuclease activity, ﬂuorescein-labelled 36-mer DNA was annealed to a fully
complementary opposite strand (control) or carrying a single nucleotide mismatch
in the central region of the strand (mismatch substrates). In total, 30 nM dsDNA
substrates were incubated with 300 nM of recombinant, tag free NucS in 20mM
Tris–HCl pH 7.5, 6mM ammonium sulfate, 2mM MgCl2 and 100mM NaCl,
0.1mgml 1 BSA and 0.1% TritonX-100. The reactions were carried out at 37 C
for 30min when 0.5 U Proteinase K was added to each reaction to digest NucS
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nuclease. Digestion was continued for 30min at 50 C. Stop solution was added
(95% formamide, 0.09% xylene cyanol), samples were boiled at 95 C for 10min
and resolved on 7M urea, 15% polyacrylamide gel in 1 TBE for 2 h. Mg, Mn and
Zn ions, and combinations of these three metals, were tested as cofactors with no
cleavage observed.
Analysis of nucS SNPs in M. tuberculosis clinical strains. Sequences from
the MT_1321 gene product were downloaded from the Ensembl database
(http://bacteria.ensembl.org/index.html), M. tuberculosis variome resource42 and
Comas et al. data43. A total of 1,600 proteins were aligned using MAFFT and the
polymorphisms were visualized with Jalview.
Construction of nucS alleles by site-directed mutagenesis. To construct nucS
alleles, wild-type nucSTB gene was PCR ampliﬁed and cloned into pUC19 to be
used as template for mutagenic PCRs. Single speciﬁc mutations were introduced
into nucSTB by PCR with the suitable mutagenic pairs of primers. Following the
PCR reaction, a DpnI digestion was carried out for 4 h at 37 C. Mutagenized
plasmids obtained after transformation into E. coli DH5a were veriﬁed by
DNA sequencing. All the nucS alleles were re-cloned into the integrative vector
pMV361 to generate a set of complementation plasmids and introduced by
transformation into M. smegmatis mc2 155 DnucS. These plasmids integrate at
a single site, attB, in the M. smegmatis chromosome.
To test the efﬁciency of each nucS allele to restore normal mutation rates, the
plasmids pMV361 carrying the mutated alleles were integrated in M. smegmatis
DnucS chromosome. Integration of each nucSTB allele in the appropriate site (attB)
of the chromosome was veriﬁed by PCR.
Computational analyses of the NucS protein. A summary of all the computa-
tional approaches conducted is depicted in Supplementary Fig. 4.
To establish how general the presence of NucS is in the domains on life, we
conducted sequence analyses to initially identify NucS proteins (Supplementary
Fig. 4). NUCS_MYCTU (M. tuberculosis NucS) and NUCS_PYRAB (P. abyssi
NucS) sequences were used to ﬁnd homologues. Each full sequence was used as an
independent query in pHMMER searches (HMMER3; http://hmmer.org/) against
the large database of the concatenated reference proteomes (2016_02 release of
17th February 2016). We next collected sequences excluding the original sequences
used to conduct the queries. The remaining sequences were ﬁltered by e-value
(removed 40.0001), bit score 450, and length (only those 475% length were
kept), and further aligned by MAFFT [http://mafft.cbrc.jp/alignment/software/]44.
The alignments were visualized with Belvu [http://sonnhammer.sbc.su.se/
Belvu.html]45 to check for quality. We removed the redundancy of the alignment
discarding sequences with more than 63% of sequence identity. We next generated
Markov proﬁles trained with the non-redundant multiple sequence alignment
(using HHMER3). For each protein, we obtained about the same 400 sequences
that would give also partial hits to different species, which suggested a potential
existence of different domains in the protein. Further checking of the sequences
retrieved the ﬁnal 370 sequences. As NucS was not identiﬁed in eukaryotes or
viruses, they were discarded for further analyses.
We constructed a phylogenetic proﬁle of NucS (Supplementary Data 1) and
mapped it into the NCBI taxonomic tree (Fig. 5, the newick tree format is available
in Supplementary Data 2). The tree was annotated using ggtree (http://
www.bioconductor.org/packages/ggtree).
Characterization of the two NucS regions. To identify potential domains in
NucS, we focused on the archaeal P. abyssi NucS, whose 3D structure was
previously resolved (PDB 2VLD chain B)11. This structure is composed by two
distinct regions: the N-terminal DNA-binding region (1–114 amino acids) and the
C-terminal catalytic region (126–233 amino acids)11. Given the absence of
structural data for the bacterial NucS protein, the M. tuberculosis NucS structure
was modelled using the archaeal P. abyssi NucS as a template using I-TASSER16
and generated a reliable model (Supplementary Fig. 3). Template and model were
structurally aligned using the Combinatorial Extension (CE) algorithm17, built-in
with PyMOL, to identify relevant residues. We used the structure-based alignment
between this template and M. tuberculosis NucS (NucS_MYCTU) (Supplementary
Fig. 3) to determine the different regions for further sequence analyses (N-terminal
and C-terminal regions). These analyses were conducted using proﬁle searches as
above and conﬁrmed by independent analyses of the PF01939 domain trained with
NucS (for details see Supplementary Methods and Supplementary Fig. 4).
We conducted sequence searches of NucS_MYCTU in the PFAM database,
where the PF01939 domain (DUF91, automatic) was identiﬁed. From the PF01939
domain (539 sequences in 464 species), only 368 entries in 363 species (archaeal
and bacterial) gave a match with the full protein (Supplementary Data File 1). The
results obtained from the PFAM database searches for the PF01939 domain, are in
agreement with the structure-based proﬁles analyses (see above) conﬁrming the
existence of two distinct regions.
Taking into account the domain boundaries established above, we next aligned
the 368 full NucS proteins (from PFAM PF01939) to proﬁles built from the
structural alignment corresponding to (i) the whole protein, (ii) the N-terminal
region (NT) and (iii) the C-terminal region (CT).
Sequence analysis of NucS domains. Using the different deﬁned regions by
structural bioinformatics, we ﬁrst conducted sequence searches against the
large database. We made non-redundant alignments of the N-terminal region
(containing 63 sequences) and the C-terminal region (containing 39 sequences)
and built proﬁle HMMs. These proﬁles were searched using pHMMER46 against
the large References Proteomes ﬁle.
Our analyses identiﬁed the C-terminal region in all the original 368 NucS
sequences (for details see Supplementary Methods and Supplementary Fig. 4). In
addition, the C-terminal was also found in proteins containing a variety of additional
protein domains in other prokaryotic species and in few additional eukaryotic
sequences. We checked the alignments to conﬁrm that the catalytic residues were
conserved, as described in the structure of P. abyssi11. When a proﬁle with the
eukaryotic sequences (excluding any bacterial or archaeal sequences) was generated,
we retrieved again the C-terminal regions of NucS above threshold at signiﬁcant
values, but we did not retrieve any other eukaryotic sequences at reliable values. On
the other hand, the N-terminal region was found mainly in bacterial and archaeal
NucS, but also in two archaeal proteins annotated as topoisomerases. A pHMMER
search of the regions of these sequences yielded the N-terminal of NucS.
Phylogenetic analyses. We conducted Maximum Likelihood (ML) phylogenetic
analyses using RAxML47 to construct phylogenetic trees that could explain the
phylogenetic proﬁle (Supplementary Fig. 4).
To run phylogenetic analyses, NucS sequences from the PF01939 domain were
used, but aligned to their corresponding structure-based regions. Sequences found
in our searches with independent regions were also included. Out of 539, 368
unique sequences aligned with the full NucS structure-based proﬁle
(Supplementary Fig. 5, Supplementary Data 3), 422 sequences containing the
C-terminal region (NucS-CT) (Supplementary Fig. 6), 370 sequences containing
the N-terminal region (NucS-NT) (Supplementary Fig. 7) were run.
Sequences were aligned to the structure-based proﬁles, and the alignments were
subjected to ML search and 1,500 bootstrap replicates using RAXML47. All free
model parameters were estimated by RAxML where we used a GAMMA model of
rate heterogeneity and ML estimate of alpha-parameter. The most likely selected
model was LG48. For accuracy and focus on our alignment, we run the sequential
version of RAxML creating various sets of starting trees (10 by manual inferring
different starting trees and 10 as automatically inferred by the programme). The
best setting (the closest likelihood to zero) was used for further calculations.
To run phylogenetic analyses, sequences from the PFAM PF01939 domain were
used, but aligned to their corresponding region. For details of the particular regions
for each domain see Supplementary Data 4. Sequences found in our searches with
NT or CT regions outside NucS were also included. Phylogenetic trees were
visualized with iTOL (http://itol.embl.de)49. The raw trees corresponding to both
CT and NT regions (Supplementary Figs 6 and 7) are available as Supplementary
Data 5 and 6 respectively.
Data availability. The authors declare that all data supporting the ﬁndings of this
study are available within the paper and its Supplementary Information ﬁles or
from the authors upon reasonable request.
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